Annual EBITDA
-$9.19 M
-$7.20 M-362.22%
December 31, 2023
Summary
- As of February 7, 2025, MGRX annual EBITDA is -$9.19 million, with the most recent change of -$7.20 million (-362.22%) on December 31, 2023.
- MGRX annual EBITDA is now -362.22% below its all-time high of -$1.99 million, reached on December 31, 2022.
Performance
MGRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.76 M
+$407.60 K+18.82%
September 1, 2024
Summary
- As of February 7, 2025, MGRX quarterly EBITDA is -$1.76 million, with the most recent change of +$407.60 thousand (+18.82%) on September 1, 2024.
- Over the past year, MGRX quarterly EBITDA has increased by +$35.40 thousand (+1.97%).
- MGRX quarterly EBITDA is now -9944.57% below its all-time high of -$17.50 thousand, reached on December 1, 2021.
Performance
MGRX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$8.85 M
+$35.40 K+0.40%
September 1, 2024
Summary
- As of February 7, 2025, MGRX TTM EBITDA is -$8.85 million, with the most recent change of +$35.40 thousand (+0.40%) on September 1, 2024.
- Over the past year, MGRX TTM EBITDA has dropped by -$1.55 million (-21.32%).
- MGRX TTM EBITDA is now -50450.86% below its all-time high of -$17.50 thousand, reached on December 1, 2021.
Performance
MGRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MGRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -362.2% | +2.0% | -21.3% |
| 3 y3 years | - | +2.0% | -21.3% |
| 5 y5 years | - | +2.0% | -21.3% |
MGRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -362.2% | at low | -9944.6% | +31.4% | <-9999.0% | +3.7% |
| 5 y | 5-year | -362.2% | at low | -9944.6% | +31.4% | <-9999.0% | +3.7% |
| alltime | all time | -362.2% | at low | -9944.6% | +31.4% | <-9999.0% | +3.7% |
Mangoceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.76 M(-18.8%) | -$8.85 M(-0.4%) |
| Jun 2024 | - | -$2.17 M(-8.3%) | -$8.88 M(-1.2%) |
| Mar 2024 | - | -$2.36 M(-7.8%) | -$8.99 M(-2.1%) |
| Dec 2023 | -$9.19 M | -$2.56 M(+42.9%) | -$9.19 M(+26.0%) |
| Sep 2023 | - | -$1.79 M(-21.3%) | -$7.29 M(+12.3%) |
| Jun 2023 | - | -$2.28 M(-10.8%) | -$6.49 M(+42.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$2.55 M(+282.2%) | -$4.54 M(+126.3%) |
| Dec 2022 | -$1.99 M | -$668.00 K(-32.6%) | -$2.01 M(+48.0%) |
| Sep 2022 | - | -$991.80 K(+202.5%) | -$1.36 M(+272.4%) |
| Jun 2022 | - | -$327.90 K(+1653.5%) | -$364.10 K(+905.8%) |
| Mar 2022 | - | -$18.70 K(+6.9%) | -$36.20 K(+106.9%) |
| Dec 2021 | - | -$17.50 K | -$17.50 K |
FAQ
- What is Mangoceuticals annual EBITDA?
- What is the all time high annual EBITDA for Mangoceuticals?
- What is Mangoceuticals annual EBITDA year-on-year change?
- What is Mangoceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Mangoceuticals?
- What is Mangoceuticals quarterly EBITDA year-on-year change?
- What is Mangoceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Mangoceuticals?
- What is Mangoceuticals TTM EBITDA year-on-year change?
What is Mangoceuticals annual EBITDA?
The current annual EBITDA of MGRX is -$9.19 M
What is the all time high annual EBITDA for Mangoceuticals?
Mangoceuticals all-time high annual EBITDA is -$1.99 M
What is Mangoceuticals annual EBITDA year-on-year change?
Over the past year, MGRX annual EBITDA has changed by -$7.20 M (-362.22%)
What is Mangoceuticals quarterly EBITDA?
The current quarterly EBITDA of MGRX is -$1.76 M
What is the all time high quarterly EBITDA for Mangoceuticals?
Mangoceuticals all-time high quarterly EBITDA is -$17.50 K
What is Mangoceuticals quarterly EBITDA year-on-year change?
Over the past year, MGRX quarterly EBITDA has changed by +$35.40 K (+1.97%)
What is Mangoceuticals TTM EBITDA?
The current TTM EBITDA of MGRX is -$8.85 M
What is the all time high TTM EBITDA for Mangoceuticals?
Mangoceuticals all-time high TTM EBITDA is -$17.50 K
What is Mangoceuticals TTM EBITDA year-on-year change?
Over the past year, MGRX TTM EBITDA has changed by -$1.55 M (-21.32%)